Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies

This study has been completed.

Study NCT00060632 Information provided by Ariad Pharmaceuticals

First Received: May 8, 2003 Last Updated: May 29, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Tumors
Lymphoma
Multiple Myeloma

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

ridaforolimus

Sponsors listed in this trial